A Molecular Model of Alzheimer Amyloid β-Peptide Fibril Formation
Open Access
- 1 April 1999
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 274 (18) , 12619-12625
- https://doi.org/10.1074/jbc.274.18.12619
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Controlling Amyloid β-Peptide Fibril Formation with Protease-stable LigandsJournal of Biological Chemistry, 1997
- A Strategy for Designing Inhibitors of β-Amyloid ToxicityJournal of Biological Chemistry, 1996
- Amyloid β-Protein and the Genetics of Alzheimer's DiseaseJournal of Biological Chemistry, 1996
- Arrest of -Amyloid Fibril Formation by a Pentapeptide LigandJournal of Biological Chemistry, 1996
- Structural model for the β-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptideNature Structural & Molecular Biology, 1995
- Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.Proceedings of the National Academy of Sciences, 1994
- Rifampicin Prevents the Aggregation and Neurotoxicity of Amyloid β Protein in VitroBiochemical and Biophysical Research Communications, 1994
- β‐Cyclodextrin interacts with the Alzheimer amyloid β‐A4 peptideFEBS Letters, 1994
- Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease βA4 peptidesJournal of Molecular Biology, 1992
- Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's diseaseJournal of Molecular Biology, 1991